204 related articles for article (PubMed ID: 30651555)
1. Recurrent activating mutations of PPARγ associated with luminal bladder tumors.
Rochel N; Krucker C; Coutos-Thévenot L; Osz J; Zhang R; Guyon E; Zita W; Vanthong S; Hernandez OA; Bourguet M; Badawy KA; Dufour F; Peluso-Iltis C; Heckler-Beji S; Dejaegere A; Kamoun A; de Reyniès A; Neuzillet Y; Rebouissou S; Béraud C; Lang H; Massfelder T; Allory Y; Cianférani S; Stote RH; Radvanyi F; Bernard-Pierrot I
Nat Commun; 2019 Jan; 10(1):253. PubMed ID: 30651555
[TBL] [Abstract][Full Text] [Related]
2. Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.
Korpal M; Puyang X; Jeremy Wu Z; Seiler R; Furman C; Oo HZ; Seiler M; Irwin S; Subramanian V; Julie Joshi J; Wang CK; Rimkunas V; Tortora D; Yang H; Kumar N; Kuznetsov G; Matijevic M; Chow J; Kumar P; Zou J; Feala J; Corson L; Henry R; Selvaraj A; Davis A; Bloudoff K; Douglas J; Kiss B; Roberts M; Fazli L; Black PC; Fekkes P; Smith PG; Warmuth M; Yu L; Hao MH; Larsen N; Daugaard M; Zhu P
Nat Commun; 2017 Jul; 8(1):103. PubMed ID: 28740126
[TBL] [Abstract][Full Text] [Related]
3. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
[TBL] [Abstract][Full Text] [Related]
6. Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα.
Choi JS; Choi SS; Kim ES; Seo YK; Seo JK; Kim EK; Suh PG; Choi JH
Cell Signal; 2015 Mar; 27(3):614-20. PubMed ID: 25479590
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis.
Ruebner M; Langbein M; Strissel PL; Henke C; Schmidt D; Goecke TW; Faschingbauer F; Schild RL; Beckmann MW; Strick R
J Cell Biochem; 2012 Jul; 113(7):2383-96. PubMed ID: 22573555
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization, transcriptional activity and nutritional regulation of peroxisome proliferator activated receptor gamma in Nile tilapia (Oreochromis niloticus).
He AY; Liu CZ; Chen LQ; Ning LJ; Qin JG; Li JM; Zhang ML; Du ZY
Gen Comp Endocrinol; 2015 Nov; 223():139-47. PubMed ID: 26002036
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
Lemkul JA; Lewis SN; Bassaganya-Riera J; Bevan DR
PLoS One; 2015; 10(5):e0123984. PubMed ID: 25954810
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of magnolol targeting both RXRα and PPARγ.
Zhang H; Xu X; Chen L; Chen J; Hu L; Jiang H; Shen X
PLoS One; 2011; 6(11):e28253. PubMed ID: 22140563
[TBL] [Abstract][Full Text] [Related]
11. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
Waku T; Shiraki T; Oyama T; Morikawa K
FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
[TBL] [Abstract][Full Text] [Related]
12. Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma.
Sanchez DJ; Missiaen R; Skuli N; Steger DJ; Simon MC
Mol Cancer Res; 2021 Apr; 19(4):598-611. PubMed ID: 33431608
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry-based FRET identifies binding intensities in PPARγ1 protein-protein interactions in living cells.
Trümper V; von Knethen A; Preuß A; Ermilov E; Hackbarth S; Kuchler L; Gunne S; Schäfer A; Bornhütter T; Vereb G; Ujlaky-Nagy L; Brüne B; Röder B; Schindler M; Parnham MJ; Knape T
Theranostics; 2019; 9(19):5444-5463. PubMed ID: 31534496
[TBL] [Abstract][Full Text] [Related]
14. Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.
Broekema MF; Massink MPG; Donato C; de Ligt J; Schaarschmidt J; Borgman A; Schooneman MG; Melchers D; Gerding MN; Houtman R; Bonvin AMJJ; Majithia AR; Monajemi H; van Haaften GW; Soeters MR; Kalkhoven E
Mol Metab; 2019 Feb; 20():115-127. PubMed ID: 30595551
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and cross-talk of peroxisome proliferator-activated receptor γ and retinoid-X receptor α in urothelial carcinomas of the bladder.
Petta E; Sotiropoulou-Bonikou G; Kourelis K; Melachrinou M; Bonikos DS
J BUON; 2010; 15(4):740-5. PubMed ID: 21229639
[TBL] [Abstract][Full Text] [Related]
16. Genomic Activation of
Goldstein JT; Berger AC; Shih J; Duke FF; Furst L; Kwiatkowski DJ; Cherniack AD; Meyerson M; Strathdee CA
Cancer Res; 2017 Dec; 77(24):6987-6998. PubMed ID: 28923856
[TBL] [Abstract][Full Text] [Related]
17. Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex.
Ricci CG; Silveira RL; Rivalta I; Batista VS; Skaf MS
Sci Rep; 2016 Jan; 6():19940. PubMed ID: 26823026
[TBL] [Abstract][Full Text] [Related]
18. Structure of full-length PPARgamma-RXRalpha: a snapshot of a functional complex?
Moras D
Cell Metab; 2009 Jan; 9(1):8-10. PubMed ID: 19117542
[TBL] [Abstract][Full Text] [Related]
19. Linked magnolol dimer as a selective PPARγ agonist - Structure-based rational design, synthesis, and bioactivity evaluation.
Dreier D; Latkolik S; Rycek L; Schnürch M; Dymáková A; Atanasov AG; Ladurner A; Heiss EH; Stuppner H; Schuster D; Mihovilovic MD; Dirsch VM
Sci Rep; 2017 Oct; 7(1):13002. PubMed ID: 29057944
[TBL] [Abstract][Full Text] [Related]
20. Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα.
Hui H; Chen Y; Yang H; Zhao K; Wang Q; Zhao L; Wang X; Li Z; Lu N; Guo Q
Int J Cancer; 2014 Mar; 134(5):1195-206. PubMed ID: 23934681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
